Golden opportunity

By Jef Akst Golden opportunity Donald Glotzer may hold the honor of being the world’s oldest “early career” scientist. Throughout his entire career as a surgeon, the thought of academic research became an itch Glotzer never had time to scratch. He had chosen surgery as his specialty thinking it would give him time to conduct laboratory experiments, but he quickly learned that he was wrong—surgery, he says, “was a total commitment

| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Donald Glotzer may hold the honor of being the world’s oldest “early career” scientist.

Throughout his entire career as a surgeon, the thought of academic research became an itch Glotzer never had time to scratch. He had chosen surgery as his specialty thinking it would give him time to conduct laboratory experiments, but he quickly learned that he was wrong—surgery, he says, “was a total commitment.” As a result, while he did publish a number of clinical and preclinical papers over the course of his career, he never got that academic experience that he had once imagined for himself. That is, until he retired.

At age 70, Glotzer officially bid his surgical career goodbye, and decided to spend his golden years in the world of academia. He interviewed a variety of other molecular and cell biologists in the Boston area to see if they thought it was a “reasonable idea ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Jef Akst

    Jef Akst was managing editor of The Scientist, where she started as an intern in 2009 after receiving a master’s degree from Indiana University in April 2009 studying the mating behavior of seahorses.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

fujirebio-square-logo

Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours